Before testing a new drug in human volunteers, in clinical trials for example, there wouldn’t be a way of knowing beforehand if the drug to be tested will be harmful to humans. Well, not before the effects become visible.
Soon, this may not be a problem anymore as Asterand plc announced recently the new test that the company came up with that may be important in predicting problems before a drug is tested in live human volunteers. The test was developed by a team of five scientists at the
"This new assay is the latest of a series of experiments that Asterand can perform on human tissue samples to help drug companies test their drug candidates thoroughly so that they can put them into the clinic with increased confidence," said Asterand CEO, Randal Charlton.
The test is based on an existing technology called immunohistochemistry (IHC) but Asterand scientists developed the test based on a highly sensitive IHC technique for testing human or humanized antibodies being considered as drug candidates for possible side effects.
Source: Asterand News
.jpg)
Appreciate your blog,mental health consumers are the least capable of self advocacy,my doctors made me take zyprexa for 4 years which was ineffective for my symptoms.I now have a victims support page against Eli Lilly for it's Zyprexa product causing my diabetes.--Daniel Haszard www.zyprexa-victims.com
Posted by: Danny Haszard | June 1, 2006 2:32 PM | Permalink to Comment